Cited by 88

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Methylation Silencing of ULK2, an Autophagy Gene, Is Essential for Astrocyte Transformation and Tumor Growth

Shukla, Sudhanshu, Patric, Irene Rosita Pia, Patil, Vikas, Shwetha, Shivayogi D., Hegde, Alangar S., Chandramouli, Bangalore A., Arivazhagan, Arimappamagan, Santosh, Vani, Somasundaram, Kumaravel·2014·Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m114.567032

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 10 references

Research works printed but not linked: 43

  1. Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4 · DOI
  2. Stupp, 2009, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, 10, 459, 10.1016/S1470-2045(09)70025-7 · DOI
  3. Nagarajan, 2009, Epigenetic mechanisms in glioblastoma multiforme, Semin Cancer Biol, 19, 188, 10.1016/j.semcancer.2009.02.005 · DOI · Paper page
  4. Reddy, 2008, Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis, Clinical Cancer Research, 14, 2978, 10.1158/1078-0432.CCR-07-4821 · DOI
  5. Sreekanthreddy, 2010, Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis, Cancer Epidemiol. Biomarkers Prev, 19, 1409, 10.1158/1055-9965.EPI-09-1077 · DOI
  6. Noushmehr, 2010, Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, 17, 510, 10.1016/j.ccr.2010.03.017 · DOI · Paper page
  7. Gonzalez-Gomez, 2003, Promoter hypermethylation of multiple genes in astrocytic gliomas, Int. J. Oncol, 22, 601
  8. Foltz, 2006, Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma, Cancer Res, 66, 6665, 10.1158/0008-5472.CAN-05-4453 · DOI
  9. Garcia-Manero, 2008, Demethylating agents in myeloid malignancies, Curr. Opin. Oncol, 20, 705, 10.1097/CCO.0b013e328313699c · DOI
  10. Codogno, 2005, Autophagy and signaling: their role in cell survival and cell death, Cell Death Differ, 12, 1509, 10.1038/sj.cdd.4401751 · DOI
  11. Degenhardt, 2006, Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis, Cancer Cell, 10, 51, 10.1016/j.ccr.2006.06.001 · DOI
  12. Kaza, 2012, Autophagy in brain tumors: a new target for therapeutic intervention, Brain Pathol, 22, 89, 10.1111/j.1750-3639.2011.00544.x · DOI
  13. Kanzawa, 2004, Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells, Cell Death Differ, 11, 448, 10.1038/sj.cdd.4401359 · DOI
  14. Arcella, 2013, Rapamycin inhibits the growth of glioblastoma, Brain Res, 1495, 37, 10.1016/j.brainres.2012.11.044 · DOI
  15. McAfee, 2012, Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency, Proc. Natl. Acad. Sci. U.S.A, 109, 8253, 10.1073/pnas.1118193109 · DOI
  16. Hu, 2012, Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma, Cancer Res, 72, 1773, 10.1158/0008-5472.CAN-11-3831 · DOI
  17. Shukla, 2013, A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-kappaB nexus, Cancer Res, 73, 6563, 10.1158/0008-5472.CAN-13-0298 · DOI
  18. Issa, 2004, CpG island methylator phenotype in cancer, Nature Reviews. Cancer, 4, 988, 10.1038/nrc1507 · DOI
  19. Baehrecke, 2005, Autophagy: dual roles in life and death?, Nature Reviews. Mol. Cell Biol, 6, 505, 10.1038/nrm1666 · DOI
  20. Scott, 2007, Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death, Curr. Biol, 17, 1, 10.1016/j.cub.2006.10.053 · DOI
  21. Yu, 2006, Autophagic programmed cell death by selective catalase degradation, Proc. Natl. Acad. Sci. U.S.A, 103, 4952, 10.1073/pnas.0511288103 · DOI
  22. Cho, 2012, Down-regulated expression of ATG5 in colorectal cancer, Anticancer Res, 32, 4091
  23. Gao, 2011, Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death, Cell Death Differ, 18, 1598, 10.1038/cdd.2011.33 · DOI · Paper page
  24. Ehrlich, 2002, DNA methylation in cancer: too much, but also too little, Oncogene, 21, 5400, 10.1038/sj.onc.1205651 · DOI
  25. Ehrlich, 2002, DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements, J. Nutrition, 132, 2424S, 10.1093/jn/132.8.2424S · DOI
  26. Fu, 2012, CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis, Clinical Cancer Research, 18, 4743, 10.1158/1078-0432.CCR-12-0707 · DOI
  27. Toyota, 1999, CpG island methylator phenotype in colorectal cancer, Proc. Natl. Acad. Sci. U.S.A, 96, 8681, 10.1073/pnas.96.15.8681 · DOI
  28. Kim, 2006, Transcriptional regulation of the human Sia-α2,3-Gal-β1,4-GlcNAc-R:α2,8-sialyltransferase (hST8Sia III) by retinoic acid in human glioblastoma tumor cell line, Biochim. Biophys. Acta, 1759, 451, 10.1016/j.bbaexp.2006.09.003 · DOI
  29. Martinez, 2009, A microarray-based DNA methylation study of glioblastoma multiforme, Epigenetics, 4, 255, 10.4161/epi.9130 · DOI
  30. Devaney, 2013, Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia, Prostate Cancer Prostatic Diseases, 16, 292, 10.1038/pcan.2013.21 · DOI
  31. Wu, 2010, Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells, Biochem. Pharmacol, 80, 262, 10.1016/j.bcp.2010.03.029 · DOI
  32. Rosenfeldt, 2011, The multiple roles of autophagy in cancer, Carcinogenesis, 32, 955, 10.1093/carcin/bgr031 · DOI
  33. Liang, 2010, Autophagy genes as tumor suppressors, Curr. Opin. Cell Biol, 22, 226, 10.1016/j.ceb.2009.11.003 · DOI
  34. Cancer Genome Atlas Research N, 2008, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 455, 1061, 10.1038/nature07385 · DOI · Paper page
  35. Liang, 2006, Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG, Nature Cell Biology, 8, 688, 10.1038/ncb1426 · DOI · Paper page
  36. Goi, 2003, Ascending colon cancer with hepatic metastasis and cholecystolithiasis in a patient with situs inversus totalis without any expression of UVRAG mRNA: report of a case, Surgery Today, 33, 702, 10.1007/s00595-002-2567-y · DOI
  37. Kim, 2008, Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability, Human Pathology, 39, 1059, 10.1016/j.humpath.2007.11.013 · DOI
  38. Takahashi, 2007, Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis, Nature Cell Biology, 9, 1142, 10.1038/ncb1634 · DOI
  39. Karantza-Wadsworth, 2007, Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis, Genes Dev, 21, 1621, 10.1101/gad.1565707 · DOI
  40. Kang, 2009, Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability, J. Pathol, 217, 702, 10.1002/path.2509 · DOI
  41. Cheong, 2014, Analysis of a lung defect in autophagy-deficient mouse strains, Autophagy, 10, 45, 10.4161/auto.26505 · DOI
  42. Jung, 2011, ULK1 inhibits the kinase activity of mTORC1 and cell proliferation, Autophagy, 7, 1212, 10.4161/auto.7.10.16660 · DOI
  43. Wei, 2011, Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis, Genes Dev, 25, 1510, 10.1101/gad.2051011 · DOI

Cited by

Sorted by citations

See all 88

Metadata

Authors
Shukla, S., Patric, I. R. P., Patil, V., Shwetha, S. D., Hegde, A. S., Chandramouli, B. A., Arivazhagan, A., Santosh, V., & Somasundaram, K.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2014-08
Volume
289
Issue
32
Pages
22306-22318
ISSN
0021-9258
Cited by
88
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review